[VALUE OF THE METOPIRONE TEST AFTER PITUITARY IMPLANTATION OF YTTRIUM IN HORMONE-DEPENDENT CANCER. IMPORTANCE AND DISADVANTAGES OF THE REPLACEMENT OF CORTISONE THERAPY BY ALDOSTERONE].
D000305:Adrenal Cortex Hormones; D000309:Adrenal Insufficiency; D000324:Adrenocorticotropic Hormone; D000450:Aldosterone; D001943:Breast Neoplasms; D003348:Cortisone / Q000627:therapeutic use*; D005260:Female; D005640:Follicle Stimulating Hormone; D006801:Humans; D007659:Ketones; D008797:Metyrapone; D000451:Mineralocorticoid Receptor Antagonists; D009369:Neoplasms / Q000628:therapy*; D010900:Pituitary Diseases; D010902:Pituitary Gland; D010910:Pituitary Irradiation; D010912:Pituitary-Adrenal Function Tests; D014556:Urine; D014594:Uterine Neoplasms; D015019:Yttrium; D015020:Yttrium Isotopes
D000305:Adrenal Cortex Hormones; D007659:Ketones; D000451:Mineralocorticoid Receptor Antagonists; D015020:Yttrium Isotopes; D000450:Aldosterone; D015019:Yttrium; D000324:Adrenocorticotropic Hormone; D005640:Follicle Stimulating Hormone; D003348:Cortisone; D008797:Metyrapone
ADRENAL CORTEX HORMONES; ADRENAL GLAND HYPOFUNCTION; ALDOSTERONE; ALDOSTERONE ANTAGONISTS; BREAST NEOPLASMS; CORTICOTROPIN; CORTISONE, THERAPEUTIC; FSH; KETONES; METYRAPONE; NEOPLASM THERAPY; PITUITARY GLAND IRRADIATION; PITUITARY-ADRENAL FUNCTION TESTS; URINE; UTERINE NEOPLASMS; YTTRIUM ISOTOPES
VALEUR DU TEST 'A LA M'ETOPIRONE APR'ES IMPLANTATION HYPOPHYSAIRE D'YTRIUM DANS LES CANCERS HORMONO-D'EPENDANTS. INT'ER ET ET INCONV'ENIENTS DU REMPLACEMENT DU TRAITEMENT CORTISONIQUE PAR L'ALDOST'ERONE.